Tag: Viral Vector Manufacturing Facility
Australia advances gene therapy manufacturing with VVMF-Mirugen collaboration
Viral Vector Manufacturing Facility Pty Ltd (VVMF) and Mirugen Pty Ltd have signed a Letter of Intent (LoI) to collaborate on the evaluation and potential development of an adeno-associated virus (AAV)-based gene therapy candidate, in a move the companies say will support Australia's advanced therapy manufacturing capabilities.















